Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Abboud

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Journal of Pediatric Hematology/Oncology|March 25, 2020
Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of LebanonHabib El-Khoury, Mohamad Chahrour, Khaled M Ghanem, et al.
Pediatric Blood & Cancer|June 30, 2017
Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and managementKhaled M Ghanem, Raghida M Dhayni, Carol Al-Aridi, et al.
Blood|December 20, 2003
Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP studyMiguel R Abboud, Joel Cure, Suzanne Granger, et al.
Journal of the American College of Cardiology|September 14, 2000
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?V Menon, J G Webb, L D Hillis, et al.
Skeletal Radiology|March 13, 2012
Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcomaKarim Z Masrouha, Khaled M Musallam, Alexis Bou Samra, et al.
American Journal of Hematology|March 29, 2014
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseMarvin E Reid, Amal El Beshlawy, Adlette Inati, et al.
Journal of Global Oncology|April 5, 2019
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in LebanonBilal Abou Ali, Mayssa Salman, Khaled M Ghanem, et al.
International Journal of Oncology|December 5, 2006
Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cellsElizabeth R Abboud, Seth B Coffelt, Yanira G Figueroa, et al.
Pediatric Blood & Cancer|August 6, 2008
Limb salvage surgery for children and adolescents with malignant bone tumors in a developing countryRachid Haidar, Said Sagghieh, Samar Muwakitt, et al.
American Journal of Hematology|July 6, 2013
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseAbdullah Kutlar, Marvin E Reid, Adlette Inati, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Journal of Pediatric Hematology/Oncology|March 25, 2020
Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of LebanonHabib El-Khoury, Mohamad Chahrour, Khaled M Ghanem, et al.
Pediatric Blood & Cancer|June 30, 2017
Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and managementKhaled M Ghanem, Raghida M Dhayni, Carol Al-Aridi, et al.
Blood|December 20, 2003
Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP studyMiguel R Abboud, Joel Cure, Suzanne Granger, et al.
Journal of the American College of Cardiology|September 14, 2000
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?V Menon, J G Webb, L D Hillis, et al.
Skeletal Radiology|March 13, 2012
Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcomaKarim Z Masrouha, Khaled M Musallam, Alexis Bou Samra, et al.
American Journal of Hematology|March 29, 2014
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseMarvin E Reid, Amal El Beshlawy, Adlette Inati, et al.
Journal of Global Oncology|April 5, 2019
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in LebanonBilal Abou Ali, Mayssa Salman, Khaled M Ghanem, et al.
International Journal of Oncology|December 5, 2006
Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cellsElizabeth R Abboud, Seth B Coffelt, Yanira G Figueroa, et al.
Pediatric Blood & Cancer|August 6, 2008
Limb salvage surgery for children and adolescents with malignant bone tumors in a developing countryRachid Haidar, Said Sagghieh, Samar Muwakitt, et al.
American Journal of Hematology|July 6, 2013
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseAbdullah Kutlar, Marvin E Reid, Adlette Inati, et al.
Pageof 16